|
|
||||||||
The Journal of Immunology, Vol 150, Issue 1 253-263, Copyright © 1993 by American Association of Immunologists
ARTICLES |
AJ Weersink, KP van Kessel, ME van den Tol, JA van Strijp, R Torensma, J Verhoef, P Elsbach and J Weiss
Eijkman-Winkler Institute of Medical and Clinical Microbiology, University of Utrecht, The Netherlands.
Several LPS-binding proteins have been identified on the surface of human granulocytes (polymorphonuclear leukocyte (PMN)). We describe a plasma-membrane associated ca. 55-kDa LPS-binding protein of human PMN that is indistinguishable from the bactericidal/permeability-increasing protein (BPI). To detect LPS-binding proteins on the cell surface, PMN were biotinylated before detergent solubilization and incubation with LPS-coated beads. Several biotinylated proteins bound to LPS-coated beads but not to uncoated beads and were characterized after elution with detergent by SDS-PAGE and western blotting using streptavidin- horseradish peroxidase. The spectrum of biotinylated proteins binding to and eluting from LPS-coated beads increased as the number of beads incubated with PMN lysate increased. However, at all concentrations of beads a 55-kDa protein was a dominant component of the eluate. Binding of the 55-kDa protein to LPS-coated beads was inhibited by lipid A, and both homologous and heterologous LPS, but not by peptidoglycan. Similar amounts of biotinylated 55-kDa LPS-binding protein were detected on PMN from patients with paroxysmal nocturnal hemoglobinuria who lacked membrane bound CD14, a known ca. 55-kDa plasma membrane-associated LPS- binding protein, indicating that the recovered biotinylated protein is not CD14. Several pieces of evidence, however, do indicate that the 55- kDa surface protein is BPI: 1) flow cytometry of PMN after labeling with rabbit anti-BPI serum and FITC-labeled goat anti-rabbit IgG revealed immunoreactive surface molecules on resting PMN and, in increased amounts, on PMN stimulated with FMLP or TNF; 2) This antiserum specifically and quantitatively inhibited binding of the biotinylated 55-kDa species to LPS-coated beads; 3) both BPI and the 55- kDa protein migrated as a doublet during SDS-PAGE and were both converted to single migrated species after N-glycosidase F treatment; 4) chemical cleavage of the biotinylated protein and native BPI with N- chlorosuccinimide yielded the same fragments. Thus, we have positively identified BPI as a LPS-binding protein on the surface of PMN. The role of this potent antibacterial, endotoxin neutralizing protein on the surface of PMN remains to be established.
This article has been cited by other articles:
![]() |
G. O. Canny and B. A. McCormick Bacteria in the Intestine, Helpful Residents or Enemies from Within? Infect. Immun., August 1, 2008; 76(8): 3360 - 3373. [Full Text] [PDF] |
||||
![]() |
G. Canny, E. Cario, A. Lennartsson, U. Gullberg, C. Brennan, O. Levy, and S. P. Colgan Functional and biochemical characterization of epithelial bactericidal/permeability-increasing protein Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G557 - G567. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Canny and S. P. Colgan Events at the Host-Microbial Interface of the Gastrointestinal Tract I. Adaptation to a microbial world: role of epithelial bactericidal/permeability-increasing protein Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G593 - G597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Engels-Deutsch, A. Pini, Y. Yamashita, Y. Shibata, Y. Haikel, M. Scholler-Guinard, and J.-P. Klein Insertional Inactivation of pac and rmlB Genes Reduces the Release of Tumor Necrosis Factor Alpha, Interleukin-6, and Interleukin-8 Induced by Streptococcus mutans in Monocytic, Dental Pulp, and Periodontal Ligament Cells Infect. Immun., September 1, 2003; 71(9): 5169 - 5177. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Canny, O. Levy, G. T. Furuta, S. Narravula-Alipati, R. B. Sisson, C. N. Serhan, and S. P. Colgan Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia PNAS, March 19, 2002; 99(6): 3902 - 3907. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Paulsen, T. Pufe, U. Schaudig, J. Held-Feindt, J. Lehmann, J.-M. Schroder, and B. N. Tillmann Detection of Natural Peptide Antibiotics in Human Nasolacrimal Ducts Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2157 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. C. de Haas, M. E. van der Tol, K. P. M. Van Kessel, J. Verhoef, and J. A. G. Van Strijp A Synthetic Lipopolysaccharide-Binding Peptide Based on Amino Acids 27-39 of Serum Amyloid P Component Inhibits Lipopolysaccharide-Induced Responses in Human Blood J. Immunol., October 1, 1998; 161(7): 3607 - 3615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Calafat, H. Janssen, A. Tool, M. A. Dentener, E. F. Knol, H. F. Rosenberg, and A. Egesten The Bactericidal/Permeability-Increasing Protein (BPI) Is Present in Specific Granules of Human Eosinophils Blood, June 15, 1998; 91(12): 4770 - 4775. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Iovine, P. Elsbach, and J. Weiss An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains PNAS, September 30, 1997; 94(20): 10973 - 10978. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Burnett, C. A. Lyden, C. J. Tindal, C. M. Cave, M. N. Marra, and J. S. Solomkin Mononuclear Cell Line THP-1 Internalizes Bactericidal/Permeability-Increasing Protein by a Non--Receptor-Mediated Mechanism Consistent With Pinocytosis Arch Surg, February 1, 1996; 131(2): 200 - 206. [Abstract] [PDF] |
||||
![]() |
R.J. Burnett, C.A. Lyden, C.J. Tindal, M.N. Marra, A.N. Neely, and J.S. Solomkin Effects of bactericidal/permeability-increasing protein upon mononuclear cell interactions with endotoxin: evidence for cell binding Innate Immunity, October 1, 1995; 2(5): 349 - 357. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |